Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 133

1.

Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial.

Geusens P, Marin F, Kendler DL, Russo LA, Zerbini CA, Minisola S, Body JJ, Lespessailles E, Greenspan SL, Bagur A, Stepan JJ, Lakatos P, Casado E, Moericke R, López-Romero P, Fahrleitner-Pammer A.

J Bone Miner Res. 2018 Jan 12. doi: 10.1002/jbmr.3384. [Epub ahead of print]

PMID:
29329484
2.

Spanish consensus on treat to target for osteoporosis.

Nogués X, Nolla JM, Casado E, Jódar E, Muñoz-Torres M, Quesada-Gómez JM, Canals L, Balcells M, Lizán L.

Osteoporos Int. 2018 Feb;29(2):489-499. doi: 10.1007/s00198-017-4310-y. Epub 2017 Nov 24.

PMID:
29177559
3.

Concordance between direct and indirect measurements of free 25-OH vitamin D.

Peris P, Filella X, Monegal A, Guañabens N, Foj L, Bonet M, Boquet D, Casado E, Cerdá D, Erra A, Gómez-Vaquero C, Martínez S, Montalá N, Pittarch C, Kanterewicz E, Sala M, Suris X, Carrasco JL; LabOscat study group.

Clin Chim Acta. 2017 Dec;475:169-171. doi: 10.1016/j.cca.2017.10.016. Epub 2017 Oct 19.

PMID:
29056531
4.

Dynamic soluble changes in sVEGFR1, HGF, and VEGF promote chemotherapy and bevacizumab resistance: A prospective translational study in the BECOX (GEMCAD 09-01) trial.

Pineda E, Salud A, Vila-Navarro E, Safont MJ, Llorente B, Aparicio J, Vera R, Escudero P, Casado E, Bosch C, Bohn U, Pérez-Carrión R, Carmona A, Ayuso JR, Ripollés T, Bouzas R, Gironella M, García-Albéniz X, Feliu J, Maurel J.

Tumour Biol. 2017 Jun;39(6):1010428317705509. doi: 10.1177/1010428317705509.

5.

Comparison of total, free and bioavailable 25-OH vitamin D determinations to evaluate its biological activity in healthy adults: the LabOscat study.

Peris P, Filella X, Monegal A, Guañabens N, Foj L, Bonet M, Boquet D, Casado E, Cerdá D, Erra A, Gómez-Vaquero C, Martínez S, Montalá N, Pittarch C, Kanterewicz E, Sala M, Suris X, Carrasco JL; LabOscat Study Group.

Osteoporos Int. 2017 Aug;28(8):2457-2464. doi: 10.1007/s00198-017-4062-8. Epub 2017 May 2.

PMID:
28466136
6.

Lipid metabolism and lung cancer.

Merino Salvador M, Gómez de Cedrón M, Moreno Rubio J, Falagán Martínez S, Sánchez Martínez R, Casado E, Ramírez de Molina A, Sereno M.

Crit Rev Oncol Hematol. 2017 Apr;112:31-40. doi: 10.1016/j.critrevonc.2017.02.001. Epub 2017 Feb 13. Review.

PMID:
28325263
7.

The role of density-dependence regulation in the misleading effect of the Aznalcollar mining spill on the booted eagle fecundity.

Gil-Jiménez E, Manzano J, Casado E, Ferrer M.

Sci Total Environ. 2017 Apr 1;583:440-446. doi: 10.1016/j.scitotenv.2017.01.098. Epub 2017 Jan 20.

PMID:
28117149
8.

Genetic polymorphisms of SCN9A are associated with oxaliplatin-induced neuropathy.

Sereno M, Gutiérrez-Gutiérrez G, Rubio JM, Apellániz-Ruiz M, Sánchez-Barroso L, Casado E, Falagan S, López-Gómez M, Merino M, Gómez-Raposo C, Rodriguez-Salas N, Tébar FZ, Rodríguez-Antona C.

BMC Cancer. 2017 Jan 19;17(1):63. doi: 10.1186/s12885-016-3031-5.

9.

Could the Addition of Cetuximab to Conventional Radiation Therapy Improve Organ Preservation in Those Patients With Locally Advanced Larynx Cancer Who Respond to Induction Chemotherapy? An Organ Preservation Spanish Head and Neck Cancer Cooperative Group Phase 2 Study.

Mesía R, Garcia-Saenz JA, Lozano A, Pastor M, Grau JJ, Martínez-Trufero J, Lambeaz J, Martínez-Galán J, Mel JR, González B, Vázquez S, Mañós M, Taberna M, Cirauqui B, Del Barco E, Casado E, Rubió-Casadevall J, Rodríguez-Jaráiz A, Cruz JJ; Spanish Head And Neck Cancer Cooperative Group (Study TTCC-2007/02).

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):473-480. doi: 10.1016/j.ijrobp.2016.11.016. Epub 2016 Nov 17.

PMID:
28011050
10.

Current evidence for cancer stem cells in gastrointestinal tumors and future research perspectives.

López-Gómez M, Casado E, Muñoz M, Alcalá S, Moreno-Rubio J, D'Errico G, Jiménez-Gordo AM, Salinas S, Sainz B Jr.

Crit Rev Oncol Hematol. 2016 Nov;107:54-71. doi: 10.1016/j.critrevonc.2016.08.006. Epub 2016 Aug 24. Review.

PMID:
27823652
11.

Secular trend in the incidence of hip fracture in Catalonia, Spain, 2003-2014.

Pueyo-Sánchez MJ, Larrosa M, Suris X, Casado E, Auleda J, Fusté J, Ortún V.

Age Ageing. 2017 Mar 1;46(2):324-328. doi: 10.1093/ageing/afw196.

PMID:
27810855
12.

Clinical pretreatment risk factors and prediction of outcome using gallium 67 scintigraphy in patients with Hodgkin's lymphoma.

Escobar IG, López A, Rubio J, Pérez-Callejo D, Barrigón DC, Alonso PT, Casado EA, Pulla MP.

Mol Clin Oncol. 2016 Jan;4(1):93-99. Epub 2015 Nov 9.

13.

An unusual cause of respiratory failure in a colon cancer patient.

Sereno M, Montoro FJ, Casanova C, Gutiérrez-Gutiérrez G, Ojeda J, Casado ES.

Mol Clin Oncol. 2015 Sep;3(5):1152-1154. Epub 2015 Jul 21.

14.

Fracture experience among participants from the FROCAT study: what thresholding is appropriate using the FRAX tool?

Azagra R, Zwart M, Aguyé A, Martín-Sánchez JC, Casado E, Díaz-Herrera MA, Moriña D, Cooper C, Díez-Pérez A, Dennison EM; GROIMAP and FROCAT Study Group.

Maturitas. 2016 Jan;83:65-71. doi: 10.1016/j.maturitas.2015.10.002. Epub 2015 Oct 21.

PMID:
26546077
15.

Diagnostic Accuracy of Tumor Markers CYFRA21-1 and CA125 in the Differential Diagnosis of Ascites.

Trapé J, Gurt G, Franquesa J, Montesinos J, Arnau A, Sala M, Sant F, Casado E, Ordeig JM, Bergos C, Vida F, Sort P, Isava Á, González M, Molina R.

Anticancer Res. 2015 Oct;35(10):5655-60.

PMID:
26408739
16.

Reference intervals for bone turnover markers in Spanish premenopausal women.

Guañabens N, Filella X, Monegal A, Gómez-Vaquero C, Bonet M, Buquet D, Casado E, Cerdá D, Erra A, Martinez S, Montalá N, Pitarch C, Kanterewicz E, Sala M, Surís X, Torres F; LabOscat Study Group.

Clin Chem Lab Med. 2016 Feb;54(2):293-303. doi: 10.1515/cclm-2015-0162.

17.

Correlation of hypertension and proteinuria with outcome in elderly bevacizumab-treated patients with metastatic colorectal cancer.

Feliu J, Salud A, Safont MJ, García-Girón C, Aparicio J, Losa F, Bosch C, Escudero P, Casado E, Jorge M, Bohn U, Pérez-Carrión R, Carmona A, Custodio AB, Maurel J.

PLoS One. 2015 Jan 20;10(1):e0116527. doi: 10.1371/journal.pone.0116527. eCollection 2015.

18.

Gene expression differences in primary colorectal tumors and matched liver metastases: chemotherapy related or tumoral heterogeneity?

López-Gómez M, Moreno-Rubio J, Suárez-García I, Cejas P, Madero R, Casado E, Jiménez AM, Sereno M, Gómez-Raposo C, Zambrana F, Merino M, Fernández-Luengas D, Feliu J.

Clin Transl Oncol. 2015 Apr;17(4):322-9. doi: 10.1007/s12094-014-1233-3. Epub 2014 Oct 10.

PMID:
25301403
19.

SMAD4 and TS expression might predict the risk of recurrence after resection of colorectal liver metastases.

López-Gómez M, Moreno-Rubio J, Suárez-García I, Cejas P, Madero R, Casado E, Jiménez A, Sereno M, Gómez-Raposo C, Zambrana F, Merino M, Fernández-Luengas D, Feliu J.

Clin Transl Oncol. 2015 Feb;17(2):133-8. doi: 10.1007/s12094-014-1202-x. Epub 2014 Jul 25.

PMID:
25060566
20.

First-line bevacizumab and capecitabine-oxaliplatin in elderly patients with mCRC: GEMCAD phase II BECOX study.

Feliu J, Salud A, Safont MJ, García-Girón C, Aparicio J, Vera R, Serra O, Casado E, Jorge M, Escudero P, Bosch C, Bohn U, Pérez-Carrión R, Carmona A, Martínez-Marín V, Maurel J.

Br J Cancer. 2014 Jul 15;111(2):241-8. doi: 10.1038/bjc.2014.346. Epub 2014 Jun 19.

21.

[Protocol of treatment of vitamin D deficiency].

Larrosa M, Casado E.

Med Clin (Barc). 2014 Dec 23;143(12):567. doi: 10.1016/j.medcli.2014.03.007. Epub 2014 Apr 24. Spanish. No abstract available.

PMID:
24768428
22.

[FRAX® thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population].

Azagra R, Roca G, Martín-Sánchez JC, Casado E, Encabo G, Zwart M, Aguyé A, Díez-Pérez A; en representación del grupo de investigación GROIMAP.

Med Clin (Barc). 2015 Jan 6;144(1):1-8. doi: 10.1016/j.medcli.2013.11.014. Epub 2014 Jan 24. Spanish.

PMID:
24461732
23.

Lung cancer and peritoneal carcinomatosis.

Sereno M, Rodríguez-Esteban I, Gómez-Raposo C, Merino M, López-Gómez M, Zambrana F, Casado E.

Oncol Lett. 2013 Sep;6(3):705-708. Epub 2013 Jul 15.

24.

Multicenter phase II study of oxaliplatin and sorafenib in advanced gastric adenocarcinoma after failure of cisplatin and fluoropyrimidine treatment. A GEMCAD study.

Martin-Richard M, Gallego R, Pericay C, Garcia Foncillas J, Queralt B, Casado E, Barriuso J, Iranzo V, Juez I, Visa L, Saigi E, Barnadas A, Garcia-Albeniz X, Maurel J.

Invest New Drugs. 2013 Dec;31(6):1573-9.

PMID:
24077981
25.

Oxaliplatin induced-neuropathy in digestive tumors.

Sereno M, Gutiérrez-Gutiérrez G, Gómez-Raposo C, López-Gómez M, Merino-Salvador M, Tébar FZ, Rodriguez-Antona C, Casado E.

Crit Rev Oncol Hematol. 2014 Jan;89(1):166-78. doi: 10.1016/j.critrevonc.2013.08.009. Epub 2013 Aug 28. Review.

PMID:
24029604
26.

Phase I study of weekly kahalalide F as prolonged infusion in patients with advanced solid tumors.

Salazar R, Cortés-Funes H, Casado E, Pardo B, López-Martín A, Cuadra C, Tabernero J, Coronado C, García M, Soto Matos-Pita A, Miguel-Lillo B, Cullell-Young M, Iglesias Dios JL, Paz-Ares L.

Cancer Chemother Pharmacol. 2013 Jul;72(1):75-83. doi: 10.1007/s00280-013-2170-5. Epub 2013 May 5.

PMID:
23645288
27.

Cancer in developing countries: the next most preventable pandemic. The global problem of cancer.

López-Gómez M, Malmierca E, de Górgolas M, Casado E.

Crit Rev Oncol Hematol. 2013 Oct;88(1):117-22. doi: 10.1016/j.critrevonc.2013.03.011. Epub 2013 Apr 19. Review.

PMID:
23602800
28.

A phase I pharmacokinetic study of PM00104 (Zalypsis) administered as a 24-h intravenous infusion every 3 weeks in patients with advanced solid tumors.

Capdevila J, Clive S, Casado E, Michie C, Piera A, Sicart E, Carreras MJ, Coronado C, Kahatt C, Soto Matos-Pita A, Fernandez Teruel C, Siguero M, Cullell-Young M, Tabernero J.

Cancer Chemother Pharmacol. 2013 May;71(5):1247-54. doi: 10.1007/s00280-013-2119-8. Epub 2013 Mar 2.

PMID:
23455428
29.

FRAX® tool, the WHO algorithm to predict osteoporotic fractures: the first analysis of its discriminative and predictive ability in the Spanish FRIDEX cohort.

Azagra R, Roca G, Encabo G, Aguyé A, Zwart M, Güell S, Puchol N, Gene E, Casado E, Sancho P, Solà S, Torán P, Iglesias M, Gisbert MC, López-Expósito F, Pujol-Salud J, Fernandez-Hermida Y, Puente A, Rosàs M, Bou V, Antón JJ, Lansdberg G, Martín-Sánchez JC, Díez-Pérez A, Prieto-Alhambra D.

BMC Musculoskelet Disord. 2012 Oct 22;13:204. doi: 10.1186/1471-2474-13-204.

30.

Management of colorectal cancer patients after resection of liver metastases: can we offer a tailored treatment?

López-Gómez M, Cejas P, Merino M, Fernández-Luengas D, Casado E, Feliu J.

Clin Transl Oncol. 2012 Sep;14(9):641-58. doi: 10.1007/s12094-012-0853-8. Epub 2012 Aug 22.

PMID:
22911546
31.

Relevance of breast cancer subtypes for magnetic resonance imaging response monitoring during neoadjuvant chemotherapy.

Gómez-Raposo C, Andreu M, Suárez-García I, Esteban MI, Carballo M, Sereno-Moyano MF, Vázquez Osorio JL, Heras J, Zambrana Tévar F, Pelayo E, López-Gómez M, García de Santiago C, Merino Salvador M, Casado E.

Clin Transl Oncol. 2012 Jun;14(6):486-8. doi: 10.1007/s12094-012-0828-9.

PMID:
22634539
32.

Upregulation of trefoil factor 3 (TFF3) after rectal cancer chemoradiotherapy is an adverse prognostic factor and a potential therapeutic target.

Casado E, Garcia VM, Sánchez JJ, Gómez Del Pulgar MT, Feliu J, Maurel J, Castelo B, Moreno Rubio J, López RA, García-Cabezas MÁ, Burgos E, de Castro J, Belda-Iniesta C, López-Gómez M, Gómez-Raposo C, Zambrana F, Sereno M, Fernández-Martos C, Vázquez P, Lacal JC, González-Barón M, Cejas P.

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1151-8. doi: 10.1016/j.ijrobp.2012.01.083. Epub 2012 Apr 18.

PMID:
22516806
33.

Long-term treatment of metastatic colorectal cancer with panitumumab.

López-Gómez M, Merino M, Casado E.

Clin Med Insights Oncol. 2012;6:125-35. doi: 10.4137/CMO.S5055. Epub 2012 Feb 28.

34.

Severe emphysematous cystitis: Outcome after seven days of antibiotics.

Sereno M, Gómez-Raposo C, Gutiérrez-Gutiérrez G, López-Gómez M, Casado E.

Mcgill J Med. 2011 Jun;13(1):13.

35.

Complete response with pegylated liposomal doxorubicin as a second-line therapy in metastatic ovarian carcinosarcoma: Significance of assessment of the response by FDG-PET.

Gómez-Raposo C, López-Gómez M, Sereno M, Zambrana F, Casado E.

Gynecol Oncol Case Rep. 2012 Mar 4;2(2):67-8. doi: 10.1016/j.gynor.2012.02.004. eCollection 2012.

36.

Internet use by cancer patients: should oncologists 'prescribe' accurate web sites in combination with chemotherapy? A survey in a Spanish cohort.

López-Gómez M, Ortega C, Suárez I, Serralta G, Madero R, Gómez-Raposo C, Sereno M, Casado E, Espinosa E, Lobo F, Feliu J.

Ann Oncol. 2012 Jun;23(6):1579-85. doi: 10.1093/annonc/mdr532. Epub 2011 Nov 22.

PMID:
22112966
37.

Clinical activity of patupilone in patients with pretreated advanced/metastatic colon cancer: results of a phase I dose escalation trial.

Melichar B, Casado E, Bridgewater J, Bennouna J, Campone M, Vitek P, Delord JP, Cerman J Jr, Salazar R, Dvorak J, Sguotti C, Urban P, Viraswami-Appanna K, Tan E, Tabernero J.

Br J Cancer. 2011 Nov 22;105(11):1646-53. doi: 10.1038/bjc.2011.438. Epub 2011 Oct 25.

38.

[Management of the patient with a high risk of fracture in clinical practice. Results from a survey of 174 Spanish Rheumatologists (OSTEOPAR project)].

Casado E, Caamaño M, Sánchez-Bursón J, Salas E, Malouf J, Rentero ML, Herrero-Beaumont G.

Reumatol Clin. 2011 Sep-Oct;7(5):305-13. doi: 10.1016/j.reuma.2010.12.008. Epub 2011 Mar 26. Spanish.

39.

Gastric tumours in hereditary cancer syndromes: clinical features, molecular biology and strategies for prevention.

Sereno M, Aguayo C, Guillén Ponce C, Gómez-Raposo C, Zambrana F, Gómez-López M, Casado E.

Clin Transl Oncol. 2011 Sep;13(9):599-610. Review.

PMID:
21865131
40.

Why birds with deferred sexual maturity are sedentary on islands: a systematic review.

Ferrer M, Bildstein K, Penteriani V, Casado E, de Lucas M.

PLoS One. 2011;6(7):e22056. doi: 10.1371/journal.pone.0022056. Epub 2011 Jul 19. Review.

41.

Defining high risk of osteoporotic fracture: a cross talk between clinical experience and guidelines recommendations.

Casado E, Malouf J, Caamaño MM, Salas E, Sánchez-Bursón JM, Rentero ML, Herrero-Beaumont G.

J Clin Rheumatol. 2011 Aug;17(5 Suppl 3):S59-66. doi: 10.1097/RHU.0b013e318227a106.

PMID:
23640502
42.

Las Alpujarras region (South East Spain) HLA genes study: evidence of a probable success of 17th century repopulation from North Spain.

Longás J, Martínez-Laso J, Rey D, Areces C, Casado EG, Parga-Lozano C, Luna F, de Salamanca ME, Moral P, Arnaiz-Villena A.

Mol Biol Rep. 2012 Feb;39(2):1387-94. doi: 10.1007/s11033-011-0873-4. Epub 2011 Jun 3.

PMID:
21633894
43.

A combined strategy of SAGE and quantitative PCR Provides a 13-gene signature that predicts preoperative chemoradiotherapy response and outcome in rectal cancer.

Casado E, García VM, Sánchez JJ, Blanco M, Maurel J, Feliu J, Fernández-Martos C, de Castro J, Castelo B, Belda-Iniesta C, Sereno M, Sánchez-Llamas B, Burgos E, García-Cabezas MÁ, Manceñido N, Miquel R, García-Olmo D, González-Barón M, Cejas P.

Clin Cancer Res. 2011 Jun 15;17(12):4145-54. doi: 10.1158/1078-0432.CCR-10-2257. Epub 2011 Apr 5.

44.

Solving man-induced large-scale conservation problems: the Spanish imperial eagle and power lines.

López-López P, Ferrer M, Madero A, Casado E, McGrady M.

PLoS One. 2011 Mar 2;6(3):e17196. doi: 10.1371/journal.pone.0017196.

45.

Hypovitaminosis D as a risk factor of hip fracture severity.

Larrosa M, Gomez A, Casado E, Moreno M, Vázquez I, Orellana C, Berlanga E, Ramon J, Gratacos J.

Osteoporos Int. 2012 Feb;23(2):607-14. doi: 10.1007/s00198-011-1588-z. Epub 2011 Mar 11.

PMID:
21394494
46.

Expression profile as predictor of relapse after adjuvant treatment in gastric cancer.

Sereno M, De Castro J, Cejas P, García-Cabezas MA, Belda C, Casado E, Feliu J, Gómez C, López M, Barón MG.

J Gastrointest Cancer. 2012 Jun;43(2):181-9. doi: 10.1007/s12029-011-9267-z.

PMID:
21360269
47.

Prediction of absolute risk of fragility fracture at 10 years in a Spanish population: validation of the WHO FRAX ™ tool in Spain.

Azagra R, Roca G, Encabo G, Prieto D, Aguyé A, Zwart M, Güell S, Puchol N, Gene E, Casado E, Sancho P, Solà S, Torán P, Iglesias M, Sabaté V, López-Expósito F, Ortiz S, Fernandez Y, Diez-Perez A.

BMC Musculoskelet Disord. 2011 Jan 28;12:30. doi: 10.1186/1471-2474-12-30.

48.

Melanoma leptomeningeal dissemination following frontoparietal metastasis surgery: Case report and review of the literature.

Moyano MS, Gutiérrez-Gutiérrez G, Rodríguez-Esteban I, Crespo GS, Casado E.

Oncol Lett. 2010 Nov;1(6):1101-1104. Epub 2010 Sep 23.

49.

Different patterns of toxicity after sequential administration of two anti-EGFR monoclonal antibodies.

López-Gómez M, Gómez-Raposo C, Sereno M, Zambrana F, Casado E.

Clin Transl Oncol. 2010 Nov;12(11):775-7. doi: 10.1007/s12094-010-0595-4.

PMID:
20974572
50.

Determination of biological variation of α-fetoprotein and choriogonadotropin (β chain) in disease-free patients with testicular cancer.

Trapé J, Franquesa J, Sala M, Domenech M, Montesinos J, Catot S, Buxó J, Casado E, Fígols C, Harillo S, Galobart J, Bella M.

Clin Chem Lab Med. 2010 Dec;48(12):1799-801. doi: 10.1515/CCLM.2010.343. Epub 2010 Sep 10.

PMID:
20828364

Supplemental Content

Loading ...
Support Center